Mobile
Search
Advanced search
Multi-criteria search
Who are we ?
Log in
Sign up
Français
English
Kusajili – Clinical trials directory
Send this study to a contact
1
Your personal information
Your name
Your e-mail
Send me a copy
2
Your recipient's information
The name of your contact
Your contact email
3
Your message
Votre message
This is an open-label, multicenter, nonrandomized Phase 1b study of oral administration of LY2157299 in combination with gemcitabine followed by a randomized, double-blind, Phase 2 study of oral administration of LY2157299 monohydrate in combination with gemcitabine versus gemcitabine plus placebo https://www.kusajili.fr:443/Trial/OAJuYuaMDUakjEUxD6FC8Q%24this-is-an-open-label-multicenter-nonrandomized-phase-1b-study-of-oral-administration-of-ly2157299-in-combination-with-gemcitab
I have read and accept the terms of use of the site and the Privacy Policy
Send your message